Showing results (251-260 of 332) with videos related to

Sort By:
Pageof 34
Clinical and Experimental Immunology|February 13, 2001
Reduced systemic IgG levels against peptidoglycan in rheumatoid arthritis (RA) patientsI A Schrijver, Y A De Man, M J Melief, et al.
The Journal of Cell Biology|October 3, 2001
Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cellsM Kleijmeer, G Ramm, D Schuurhuis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1995
Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptidesM E Ressing, A Sette, R M Brandt, et al.
Cancer Research|June 15, 1995
Eradication of large human B cell tumors in nude mice with unconjugated CD20 monoclonal antibodies and interleukin 2E Hooijberg, J J Sein, P C van den Berk, et al.
British Journal of Cancer|May 1, 1992
A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part I: Clinical aspectsL T Vlasveld, E M Rankin, A Hekman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2000
MHC class I antigen processing of an adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cellsA J Sijts, S Standera, R E Toes, et al.
Molecular Pharmacology|August 12, 2011
Duration of action of a broad range of selective κ-opioid receptor antagonists is positively correlated with c-Jun N-terminal kinase-1 activationErica J Melief, Mayumi Miyatake, F Ivy Carroll, et al.
Transplant Immunology|September 1, 1996
Chronic rejection of concordant aortic xenografts in the hamster-to-rat modelM Scheringa, B Buchner, R W de Bruin, et al.
The Journal of Experimental Medicine|September 19, 2001
Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responsesR P Sutmuller, L M van Duivenvoorde, A van Elsas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 1998
Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cellsR E Toes, E I van der Voort, S P Schoenberger, et al.
Pageof 34